Favorable risk human AML RNA-Seq

NIAID Data Ecosystem2026-05-01 收录

急性髓系白血病转录组学

预后风险突变分析

数据链接：

https://www.ncbi.nlm.nih.gov/sra/SRP461405 数据链接链接失效反馈

官方服务：

资源简介：

RNA sequencing performed on presentation bone marrow biopsies from human patients with the indicated favorable risk mutation/oncofusion

创建时间：

2023-09-21

caf69264-89b6-44e0-b35c-badf77ba71eb - samples

急性髓系白血病转录组学

造血细胞分化

Single-cell RNA sequencing was performed on bone marrow mononuclear cells of a patient with acute myeloid leukemia with erythroid differentiation of the blasts and on peripheral blood mononuclear cell

NIAID Data Ecosystem60

RNA-seq of LSC-like and Mature populations from human AML patient samples. RNA-seq of LSC-like and Mature populations from human AML patient samples

急性髓系白血病转录组学

干细胞分子特征

Acute myeloid leukemia (AML) is a highly heterogeneous disease and reliable detection of leukemic stem cells (LSCs) across genetic subclasses has proven difficult. We aimed to transcriptionally charac

NIAID Data Ecosystem20

d0b5f787-7b20-4b15-85c6-8bd1adfd4289 - samples

急性髓系白血病转录组学

癌症突变亚型分析

Using a novel sorting strategy, we performed ultra low input RNAseq from FACS-sorted populations from diagnostic DNMT3Amut and NPM1mut AML patients. Primary samples were retrospectively collected bas

NIAID Data Ecosystem10

RNA-seq in 73 B-lineage ALL patients. RNA-seq in 73 B-lineage ALL patients

急性髓系白血病转录组学

药物敏感性关联分析

RNA-seq from RNA isolated from bone marrow or peripheral blood of newly diagnosed acute lymphoblastic leukemia patients on TotalXVI protocol Overall design: LC50 determination performed with concordan

NIAID Data Ecosystem50

Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)

急性髓系白血病转录组学

药物作用机理分析

Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)

ChEBI2008-04-07 更新10

Favorable risk human AML RNA-Seq

资源简介：

相关数据集